ASH 2020 CML Conference Report
The 62nd ASH Annual Meeting and Exposition organised by the American Society of Hematology was finally held virtually on December 5-8, 2020, given the coronavirus outbreak situation.
We have prepared a Conference Report in order to provide you the latest updates on the management of chronic myeloid leukemia and the most important highlights presented in this key meeting for the CML community.
Download the ASH 2020 Conference report by clicking on the image below:
In Memoriam of Ahmed Awad
The entire chronic myeloid leukemia community mourns the loss of our dear friend Ahmed Awad from Egypt.
Ahmed was a chronic myeloid leukemia patient himself for many years and founder of our member organisation in Egypt "Power of CML" in June 2014. He was a dedicated patient advocate in his country as well as a strong supporter of the global initiatives of the CML Advocates Network, as co-organizer of the World CML Day events in the Middle East and Africa region in the past years, among others.
In Ahmed owns words, "Once I got diagnosed with CML, I started getting depressed. However, I recognized how to overcome this feeling and how to help other patients to know more about the development of the latest remedy methods."
Our Steering Committee representative of the region, Bahija Gouimi, President of AMAL in Morocco, states: "I lost my best friend. He was a son for me. He was a passionate advocate, always fighting to improve the quality of drugs and patients' lives in Egypt."
We have lost a dear friend and valued dedicated colleague. Our grief and sadness at this time are little compared to what Ahmed’s family must be feeling. Our hearts and prayers go out to them.
Rest in peace, dear Ahmed.
Our CMLCAB Abstract published in the OJRD Supplement
Orphanet Journal of Rare Diseases (OJRD), which is the official journal of Orphanet, the portal for rare diseases and orphan drugs, has recently published a special supplement featuring over 50 selected poster and speaker presentation abstracts from the 10th European Conference on Rare Diseases & Orphan Products (ECRD 2020).
This journal, published by BioMed Central, is an open access online journal focused on rare diseases and orphan products and publishes high-quality reviews on specific topics.
Our Abstract "CML Advocates Network implementation of the Community Advisory Board (CAB) model" has been included as part of this collection as P28 (page 17).
See the OJRD Supplement: 10th European Conference on Rare Diseases & Orphan Products (ECRD 2020). Orphanet J Rare Dis 15, 310 (2020). https://doi.org/10.1186/s13023-020-01550-1
Download the PDF by clicking on the image below:
Welcome, UDON CML Patients Group from Thailand!
We hereby proudly welcome a new member organisation in the CML Advocates Network:
UDON CML Patients Group, based in Thailand.
In Memoriam of Stanislav Kulikov
It is with great sadness that we share that our friend, colleague, and CML patient advocate Stanislav Petrovich Kulikov passed away on 18th December 2020, due to a sudden illness.
CML Advocates Network loses a friend who was also a very active patient advocate, leading the Sodeystvie (Assistance) patient’s organisation as Vice-President in the Volga Federal District and always strongly supporting the network’s initiatives and projects.
Stanislav was a very special, helpful person and a passionate advocate. In words of our colleague Irina from the Patient Foundation "Drop of Blood” in Ukraine, “Stan was the best friend to patients from Ukraine. He was the best fighter for the rights of patients in Russia, broughting good and light to people living with blood cancer in the region. We will always miss him. Thank you, Stan, for all the warmth and kindness.”
He never rested from advocating for leukemia patients and trying to improve diagnosis, access, and quality of life for CML patients in Russia and its neighboring countries. He participated in over ten CML Horizons International Conferences, actively collaborating in many different activities of the global network as the World CML Day or the TFR for CML patient’s research.
“All of us will remember Stan as the happiest friend, who restlessly dedicated his time to improve the quality of our lives and make this world a little bit better with humility and kindness”, Dražen Vincek from Croatia stated.
We owe Stanislav a lot, not only for all that he has done for the CML Advocates Network and for Russian patients but also for being a dear friend and a great advocate. We will miss him very much, and we wish his family and all friends all the strength and wisdom they need in these difficult times. Rest in peace, dear Stanislav.
- The CML Advocates Network Steering Committee on behalf of the CML advocates global community -
ELN Recommendations 2020
The therapeutic landscape of CML has profoundly changed over the past 7 years so the European Leukemia Net convened an expert panel to critically evaluate the current evidence and update its previous recommendations.
The new "European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia" were published in March 2020 in the prestigious journal Leukemia.
In order to improve the information available to patients and support them to access these guidelines, we have developed once more a patient-friendly summary of recommendations for CML management based on the ELN Recommendations 2020.
It is made available at this stage in 13 languages and more are coming. We are welcome to initiate community translations by member organisations of CML Advocates Network under the provision that members have them co-validated by a local CML specialist with whom the member organisation regularly works. If you would like to help us making the summary available in your language, please, contact us at info@cmladvocates.net.
This is a result of a genuinely patient-led project and aims to help patients to better understand CML management and communicate with their doctors on treatment and diagnostics.
Download the Patient-friendly Summary of the ELN 2020 CML Treatment Recommendations
